Malaria vaccine safety study for children ages 5 months to 5 years
Part of Infections clinical trials.
This trial tests a new malaria vaccine in healthy children. It aims to see if the vaccine is safe and how well it works in children who have had their regular childhood shots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be 5 months to 5 years old when getting the first vaccine dose.
- Your child should be generally healthy and have completed their routine childhood vaccinations.
- Your child must test negative for HIV, hepatitis B, and hepatitis C.
- Your child must have a hemoglobin level above 8 g/dL (a measure of red blood cells).
- Your child must have been born after at least 37 weeks of pregnancy.
- Your child should not have received any malaria vaccine before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new long-acting injection to prevent malaria. It checks safety and how the body handles the drug in healthy adults and adolescents in Rwanda.
This study checks how well evidence about the RTS,S/AS01 malaria vaccine helps inform health policy. You may be included if you live in a specific local area and your child is the right age for the vaccine schedule, and you agree to participate.
This study looks at how well the R21/Matrix-M malaria vaccine works in real-life settings for children under 5. If your child is eligible for the vaccine and has a fever, they may be able to join and help us understand the vaccine's impact.
This study tests a new malaria vaccine (called R21/MM) given in different doses and forms. If you qualify, you'll help find a better way to protect against malaria.
This study looks at lab tests for malaria vaccine candidates in pregnant women who currently have malaria. It may help researchers understand which vaccine approaches are safest and most promising for pregnancy.
This study screens healthy adults to see who can join future malaria vaccine or investigational malaria drug studies, including a controlled malaria exposure. It may help researchers test safer vaccines/drugs, but participation requires good health and strict medical eligibility.
Hear when a new Malaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.